Studies have been initiated to understand the molecular basis of endothelial cell growth regulation. We have isolated from human endothelial cell extracellular matrix a heparan sulfate proteoglycan which binds and potentiates the mitogenic activity of acidic fibroblast growth factor. Our hypothesis states that human endothelial cells synthesize into the extracellular matrix a heparan sulfate proteoglycan which binds and sequester growth factors such as acidic fibroblast growth factor. The extracellular matrix heparan sulfate proteoglycan modulates the mitogenic potential of acidic fibroblast growth factor. The acidic fibroblast growth factor, in turn, controls the synthesis and/or turnover of the extracellular matrix heparan sulfate proteoglycan which binds the growth factors and thus modualtes the interaction of the growth factors with the endothelial cells. The extracellular matrix heparan sulfate proteoglycan, as well as the carbohydrate side chains and the core protein will be isolated and structurally characterized. The structure of the acidic fibroblast growth factor binding region in the extracellular matrix heparan sulfate proteoglycan will be elucidated. In order to determine if the heparan sulfate proteoglycan increases the affinity of acidic fibroblast growth factor for the fibroblast growth factor receptor, the interaction of extracellular matrix heparan sulfate proteoglycan and acidic fibroblast growth factor will be further investigated. The capacity of the isolated extracellular matrix to bind acidic fibroblast growth factor and potentiate endothelial cell growth will be studied. We will evaluate the hypothesis that acidic fibroblast growth factor controls the synthesis and turnover of extracellular matrix heparan sulfate proteoglycan which binds and potentiates the mitogenic activity of acidic fibroblast growth factor. Finally, we will elucidate the structural and functional relationship between the cellular heparan sulfate proteoglycans which binds acidic fibroblast growth factor and the extracellular matrix heparan sulfate proteoglycan which binds acidic fibroblast growth factor. This proposal will test a hypothesis that will provide new information on the growth regulation of human endothelial cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL037025-01A2
Application #
3352519
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1988-07-01
Project End
1991-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Montefiore Medical Center (Bronx, NY)
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10467
Alston, W K; Elliott, D A; Epstein, M E et al. (1997) Extracellular matrix heparan sulfate modulates endothelial cell susceptibility to Staphylococcus aureus. J Cell Physiol 173:102-9
Shuter, J; Hatcher, V B; Lowy, F D (1996) Staphylococcus aureus binding to human nasal mucin. Infect Immun 64:310-8
Yao, L; Bengualid, V; Lowy, F D et al. (1995) Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression. Infect Immun 63:1835-9
Calderon, T M; Factor, S M; Hatcher, V B et al. (1994) An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels. Lab Invest 70:836-49
Margossian, S S; Hatcher, V B; Taylor, S (1993) Kinetics of hydrolysis of cardiac S1 heavy chain isoforms and identification of light chain and actin binding sites. Cardiovasc Res 27:216-21
Silbiger, S; Schlondorff, D; Crowley, S et al. (1993) The effect of glucose on proteoglycans produced by cultured mesangial cells. Diabetes 42:1815-22
Tompkins, D C; Blackwell, L J; Hatcher, V B et al. (1992) Staphylococcus aureus proteins that bind to human endothelial cells. Infect Immun 60:965-9
Elliott, D A; Hatcher, V B; Lowy, F D (1991) A 220-kilodalton glycoprotein in yeast extract inhibits Staphylococcus aureus adherence to human endothelial cells. Infect Immun 59:2222-3
Tsai, H M; Nagel, R L; Hatcher, V B et al. (1991) The high molecular weight form of endothelial cell von Willebrand factor is released by the regulated pathway. Br J Haematol 79:239-45
Tanowitz, H B; Burns, E R; Sinha, A K et al. (1990) Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. Am J Trop Med Hyg 43:274-81

Showing the most recent 10 out of 13 publications